Skip to the main content.

1 min read

Full-Time Equivalent Programs: Outsourcing Analytical Testing

Alcami’s end-to-end analytical testing platform supports clients’ programs through every stage of a product’s life cycle, from early-phase development activities to commercial support for both small and large molecule products. As a fully integrated CDMO, we have expanded our services by adjusting to market and regulatory changes. The expansion of the Extended Workbench offering includes the development of a quality system with third-party audit reports and the addition of capabilities like rapid sterility testing to address client needs.

The Extended Workbench is a Full-time Equivalent (FTE) program tailored to a client’s specific needs. Dedicated employees focus solely on individual client projects to provide a flexible and controlled outsourcing laboratory service package. The program can be customized based on the product phase and the number of products.

Clinical phase development platforms can be designed to be adaptable, granting clients the freedom to adjust priorities based on their needs and results. Programs can also be designed for short-term use with a fixed-cost schedule, providing cost control during a product’s riskier development phase.

The Extended Workbench also provides clients with a single vendor laboratory resource for their analytical needs during the established phases of a product and portfolio. In these stages, where quality control analysis is needed, clients can control their costs and priorities while still performing routine product release, stability, and raw material evaluations.

Alcami’s efforts to expand its range of services include the introduction of rapid sterility technology and biosimilar analytical capabilities. We can release clients’ products to market faster, reduce inventory holding times, and provide more robust computer-generated sterility results, eliminating subjectivity and individual analyst observations. Also, as the industry continues to transition to more complex formulations and more biologics come off-patent, our ability to handle complex entities in the coming years is critical.

Alcami contributed to an article in Drug Development & Delivery titled Outsourcing Analytical Testing: Novel Services Elicit Consistent, Quantifiable, & Faster Results. Please visit their website for the full article.